{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:23:02Z","timestamp":1794320582596,"version":"4.9.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This review highlights recent advances in the pathophysiology, diagnosis, and treatment of cardiac disease in patients with Eosinophilic granulomatosis with polyangiitis (EGPA). We outline a diagnostic approach to facilitate early identification of affected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent advancements in diagnostic techniques including cardiac magnetic resonance (CMR) have improved recognition of cardiac disease in patients with EGPA. CMR has demonstrated a high prevalence of cardiac abnormalities, even in the absence of clinical symptoms, electrocardiographic or echocardiographic findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Cardiac disease is a major cause of mortality in patients with EGPA, accounting for around 50% of disease-related deaths. However, due to the lack of standardised screening and diagnostic criteria, the true incidence remains unknown. Systemic immunosuppressive therapy is warranted to prevent acute complications as well as mitigate the long-term impact of chronic inflammation and tissue damage. Given the challenges in early detection and the prognostic significance of cardiac involvement, we recommend including CMR in the baseline evaluation of all EGPA patients at diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-025-02258-z","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:38:28Z","timestamp":1752140308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis"],"prefix":"10.1007","volume":"27","author":[{"given":"Mukunthan","family":"Srikantharajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Wilson-Morkeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McAdoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Youngstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"sup1","key":"2258_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/00325481.2022.2134624","volume":"135","author":"A Villa-Forte","year":"2023","unstructured":"Villa-Forte A. Eosinophilic granulomatosis with polyangiitis. Postgrad Med. 2023;135(sup1):52\u201360.","journal-title":"Postgrad Med"},{"issue":"1","key":"2258_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71.","journal-title":"Nat Rev Dis Primers"},{"key":"2258_CR3","doi-asserted-by":"crossref","unstructured":"Watanabe R, Hashimoto M. Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations. J Clin Med. 2023 Sep 15;12(18):5996.","DOI":"10.3390\/jcm12185996"},{"key":"2258_CR4","doi-asserted-by":"crossref","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","DOI":"10.1002\/art.37715"},{"issue":"10","key":"2258_CR5","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1093\/rheumatology\/keab027","volume":"60","author":"E Garcia-Vives","year":"2021","unstructured":"Garcia-Vives E, Rodriguez-Palomares JF, Harty L, Solans-Laque R, Jayne D. Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal. Rheumatology (Oxford). 2021;60(10):4538\u201347.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2258_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","volume":"26","author":"A Mahr","year":"2014","unstructured":"Mahr A, Moosig F, Neumann T, Szczeklik W, Taill\u00e9 C, Vaglio A, et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss). Curr Opin Rheumatol. 2014;26(1):16\u201323.","journal-title":"Curr Opin Rheumatol"},{"key":"2258_CR7","doi-asserted-by":"crossref","unstructured":"Liu X, Zhou Y, Li J, Guo T, Lv Z, Zhang D, et al. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy. Rheumatology (Oxford). 2025 Feb 1;64(2):722\u2013731.","DOI":"10.1093\/rheumatology\/keae085"},{"issue":"1","key":"2258_CR8","first-page":"18","volume":"15","author":"M Pakbaz","year":"2020","unstructured":"Pakbaz M, Pakbaz M. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: A Meta-Analysis of 62 case reports. J Tehran Heart Cent. 2020;15(1):18\u201326.","journal-title":"J Tehran Heart Cent"},{"issue":"3","key":"2258_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/rheumatology\/keab514","volume":"61","author":"S Sartorelli","year":"2022","unstructured":"Sartorelli S, Chassagnon G, Cohen P, Dunogu\u00e9 B, Pu\u00e9chal X, R\u00e9gent A, et al. Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg\u2013Strauss). Rheumatology. 2022;61(3):1175\u201384.","journal-title":"Rheumatology"},{"issue":"1","key":"2258_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine. 1996;75(1):17\u201328.","journal-title":"Medicine"},{"issue":"9","key":"2258_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2015.04.013","volume":"14","author":"B Dunogu\u00e9","year":"2015","unstructured":"Dunogu\u00e9 B, Terrier B, Cohen P, Marmursztejn J, Legmann P, Mouthon L, et al. Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patients. Autoimmun Rev. 2015;14(9):774\u201380.","journal-title":"Autoimmun Rev"},{"key":"2258_CR12","doi-asserted-by":"publisher","first-page":"627776","DOI":"10.3389\/fmed.2021.627776","volume":"8","author":"F Fagni","year":"2021","unstructured":"Fagni F, Bello F, Emmi G. Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology. Front Med (Lausanne). 2021;8:627776.","journal-title":"Front Med (Lausanne)"},{"key":"2258_CR13","doi-asserted-by":"crossref","unstructured":"Piccirillo F, Mastroberardino S, Nafisio V, Fiorentino M, Segreti A, Nusca A et al. Eosinophilic myocarditis: from bench to bedside. Biomedicines. 2024;12(3).","DOI":"10.3390\/biomedicines12030656"},{"issue":"25","key":"2258_CR14","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","volume":"289","author":"KR Acharya","year":"2014","unstructured":"Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem. 2014;289(25):17406\u201315.","journal-title":"J Biol Chem"},{"issue":"12","key":"2258_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/nri.2017.95","volume":"17","author":"PF Weller","year":"2017","unstructured":"Weller PF, Spencer LA. Functions of tissue-resident eosinophils. Nat Rev Immunol. 2017;17(12):746\u201360.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"2258_CR16","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859\u201372.","journal-title":"Blood"},{"issue":"7","key":"2258_CR17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.20161070","volume":"214","author":"S Uderhardt","year":"2017","unstructured":"Uderhardt S, Ackermann JA, Fillep T, Hammond VJ, Willeit J, Santer P, et al. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J Exp Med. 2017;214(7):2121\u201338.","journal-title":"J Exp Med"},{"issue":"2","key":"2258_CR18","first-page":"521","volume":"140","author":"H Noguchi","year":"1992","unstructured":"Noguchi H, Kephart GM, Colby TV, Gleich GJ. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol. 1992;140(2):521\u20138.","journal-title":"Am J Pathol"},{"issue":"6","key":"2258_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/hrt.81.6.669","volume":"81","author":"M Arima","year":"1999","unstructured":"Arima M, Kanoh T. Eosinophilic myocarditis associated with dense deposits of eosinophil cationic protein (ECP) in endomyocardium with high serum ECP. Heart. 1999;81(6):669\u201371.","journal-title":"Heart"},{"issue":"8","key":"2258_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.healun.2014.02.023","volume":"33","author":"M Groh","year":"2014","unstructured":"Groh M, Masciocco G, Kirchner E, Kristen A, Pellegrini C, Varnous S, et al. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Heart Lung Transpl. 2014;33(8):842\u201350.","journal-title":"J Heart Lung Transpl"},{"key":"2258_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2020.12.008","volume":"85","author":"M Zampieri","year":"2021","unstructured":"Zampieri M, Emmi G, Beltrami M, Fumagalli C, Urban ML, Dei LL, et al. Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): prospective evaluation at a tertiary referral centre. Eur J Intern Med. 2021;85:68\u201379.","journal-title":"Eur J Intern Med"},{"issue":"19","key":"2258_CR22","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","volume":"70","author":"M Brambatti","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017;70(19):2363\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2258_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/heartjnl-2020-317202","volume":"108","author":"A Bondue","year":"2022","unstructured":"Bondue A, Carpentier C, Roufosse F. Hypereosinophilic syndrome: considerations for the cardiologist. Heart. 2022;108(3):164\u201371.","journal-title":"Heart"},{"key":"2258_CR24","doi-asserted-by":"publisher","first-page":"319215","DOI":"10.1155\/2014\/319215","volume":"2014","author":"A Agrawal","year":"2014","unstructured":"Agrawal A, Gang TB, Rusi\u00f1ol AE. Recognition functions of pentameric C-reactive protein in cardiovascular disease. Mediators Inflamm. 2014;2014:319215.","journal-title":"Mediators Inflamm"},{"key":"2258_CR25","doi-asserted-by":"crossref","unstructured":"Hua A, Sularz A, Wheen P, Alam V, Rajani R, Chiribiri A et al. Detection of cardiac involvement in eosinophilic granulomatosis with polyangiitis (EGPA) with multiparametric cardiovascular magnetic resonance (CMR). JACC Cardiovasc Imaging. 2024.","DOI":"10.1016\/j.jocmr.2024.100895"},{"issue":"11","key":"2258_CR26","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13(11):e007405.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"2258_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation. 2018;138(11):1088\u201399.","journal-title":"Circulation"},{"issue":"8","key":"2258_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic Antibody-Associated vasculitis. Arthritis Rheumatol. 2021;73(8):1366\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"35","key":"2258_CR29","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European society of cardiology working group on myocardial and pericardial disease. Eur Heart J. 2017;38(35):2649\u201362.","journal-title":"Eur Heart J"},{"issue":"11","key":"2258_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11926-022-01087-1","volume":"24","author":"M Bond","year":"2022","unstructured":"Bond M, Fagni F, Moretti M, Bello F, Egan A, Vaglio A, et al. At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement. Curr Rheumatol Rep. 2022;24(11):337\u201351.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2258_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French vasculitis study group cohort. Arthritis Rheum. 2013;65(1):270\u201381.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2258_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1540-8175.2006.00288.x","volume":"23","author":"R Shah","year":"2006","unstructured":"Shah R, Ananthasubramaniam K. Evaluation of cardiac involvement in hypereosinophilic syndrome: complementary roles of transthoracic, transesophageal, and contrast echocardiography. Echocardiography. 2006;23(8):689\u201391.","journal-title":"Echocardiography"},{"key":"2258_CR33","doi-asserted-by":"crossref","unstructured":"Sridharan S, Nanthakumaran S, Somagutta MR, Pagad S, Arnold AA, May V et al. The Critical Role of Cardiac Magnetic Resonance Imaging in Evaluating Patients With Eosinophilic Granulomatosis With Polyangiitis. Cureus. 2020.","DOI":"10.7759\/cureus.10279"},{"issue":"17","key":"2258_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J Am Coll Cardiol. 2009;53(17):1475\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2258_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10554-017-1063-9","volume":"34","author":"J Lagan","year":"2018","unstructured":"Lagan J, Schmitt M, Miller CA. Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases. Int J Cardiovasc Imaging. 2018;34(1):35\u201354.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"2258_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/mr\/road001","volume":"34","author":"J Fijolek","year":"2023","unstructured":"Fijolek J, Wiatr E, Bujnowski P, Piotrowska-Kownacka D, Roszkowski-Sliz K. Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the Pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland. Mod Rheumatol. 2023;34(1):157\u201366.","journal-title":"Mod Rheumatol"},{"key":"2258_CR37","doi-asserted-by":"publisher","first-page":"913724","DOI":"10.3389\/fcvm.2022.913724","volume":"9","author":"H Yamamoto","year":"2022","unstructured":"Yamamoto H, Hashimoto K, Ikeda Y, Isogai J, Hashimoto T. The diagnostic challenge of eosinophilic granulomatosis with polyangiitis presenting as acute eosinophilic myocarditis: case report and literature review. Front Cardiovasc Med. 2022;9:913724.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"2258_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","volume":"88","author":"T Neumann","year":"2009","unstructured":"Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine. 2009;88(4):236\u201343.","journal-title":"Medicine"},{"issue":"18","key":"2258_CR39","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2169\/internalmedicine.0330-17","volume":"57","author":"T Nakayama","year":"2018","unstructured":"Nakayama T, Murai S, Ohte N. Dilated cardiomyopathy with eosinophilic granulomatosis with polyangiitis in which active myocardial inflammation was only detected by endomyocardial biopsy. Intern Med. 2018;57(18):2675\u20139.","journal-title":"Intern Med"},{"issue":"3","key":"2258_CR40","first-page":"305","volume":"34","author":"MY Hung","year":"2007","unstructured":"Hung MY, Hung MJ, Cheng CW. Use of gallium 67 scintigraphy to differentiate acute myocarditis from acute myocardial infarction. Tex Heart Inst J. 2007;34(3):305\u20139.","journal-title":"Tex Heart Inst J"},{"issue":"4","key":"2258_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/rheumatology\/kes155","volume":"52","author":"J Marmursztejn","year":"2013","unstructured":"Marmursztejn J, Guillevin L, Trebossen R, Cohen P, Guilpain P, Pagnoux C, et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford). 2013;52(4):642\u201350.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"2258_CR42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s00259-004-1550-9","volume":"31","author":"H Morita","year":"2004","unstructured":"Morita H, Yokoyama I, Yamada N, Uno K, Nagai R. Usefulness of 18FDG\/13\u00a0N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging. 2004;31(8):1218.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2258_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/bmb\/ldv033","volume":"115","author":"V Kouranos","year":"2015","unstructured":"Kouranos V, Wells AU, Sharma R, Underwood SR, Wechalekar K. Advances in radionuclide imaging of cardiac sarcoidosis. Br Med Bull. 2015;115(1):151\u201363.","journal-title":"Br Med Bull"},{"issue":"6","key":"2258_CR44","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ihj.2015.07.049","volume":"67","author":"G Dendramis","year":"2015","unstructured":"Dendramis G, Paleologo C, Piraino D, Arrotti S, Assennato P. Coronary involvement in Churg-Strauss syndrome. Indian Heart J. 2015;67(6):586\u20138.","journal-title":"Indian Heart J"},{"key":"2258_CR45","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.jtauto.2021.100118","volume":"4","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, Yang Z, Peng Y, Wang L, Yuan X. Diagnosis and treatment of eosinophilic myocarditis. J Transl Autoimmun. 2021;4:100118.","journal-title":"J Transl Autoimmun"},{"issue":"6","key":"2258_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","volume":"19","author":"G Emmi","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, Bajema IM, Berti A, Burns S, et al. Evidence-Based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023;19(6):378\u201393.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2258_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10554-012-0158-6","volume":"29","author":"T Miszalski-Jamka","year":"2013","unstructured":"Miszalski-Jamka T, Szczeklik W, Soko\u0142owska B, Karwat K, Belzak K, Mazur W, et al. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener\u2019s) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging. 2013;29(4):843\u201353.","journal-title":"Int J Cardiovasc Imaging"},{"key":"2258_CR48","volume-title":"Cardiac involvement in EGPA: interval CMR imaging [abstract]o monitor [abstract]esponse [abstract]o [abstract]reatment [Abstract]","author":"M Srikantharajah","year":"2022","unstructured":"Srikantharajah M, Ward K, Prendecki M, Cairns T, Pusey C, Cole G, et al. Cardiac involvement in EGPA: interval CMR imaging [abstract]o monitor [abstract]esponse [abstract]o [abstract]reatment [Abstract]. In Dublin: Vasculitis and ANCA Workshop; 2022."},{"issue":"12","key":"2258_CR49","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology. 2014;53(12):2306\u20139.","journal-title":"Rheumatology"},{"key":"2258_CR50","doi-asserted-by":"crossref","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023.","DOI":"10.1136\/ard-2024-225606"},{"issue":"8","key":"2258_CR51","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11739-019-02166-5","volume":"14","author":"C Marvisi","year":"2019","unstructured":"Marvisi C, Sinico RA, Salvarani C, Jayne D, Prisco D, Terrier B, et al. New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA study group. Intern Emerg Med. 2019;14(8):1193\u20137.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2258_CR52","first-page":"177","volume":"14","author":"H Hase","year":"2016","unstructured":"Hase H, Yamamoto T, Saito T, Yamazaki H, Kuno T, Tabei R, et al. Successful treatment using corticosteroids in early phase of eosinophilic myocarditis with eosinophilic granulomatosis with polyangiitis. J Cardiol Cases. 2016;14(6):177\u201380.","journal-title":"J Cardiol Cases"},{"issue":"2","key":"2258_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/heartjnl-2015-307959","volume":"102","author":"R Mankad","year":"2016","unstructured":"Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart. 2016;102(2):100\u20136.","journal-title":"Heart"},{"issue":"3","key":"2258_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.rdc.2019.04.006","volume":"45","author":"SE Sattui","year":"2019","unstructured":"Sattui SE, Spiera RF. Treatment of antineutrophil cytoplasmic Antibody-Associated vasculitis: is there still a role for cyclophosphamide?? Rheum Dis Clin North Am. 2019;45(3):379\u201398.","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"2258_CR55","doi-asserted-by":"publisher","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K de Groot","year":"2009","unstructured":"de Groot K, Harper L, Jayne DRW, Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670\u201380.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2258_CR56","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.22679","volume":"57","author":"P Cohen","year":"2007","unstructured":"Cohen P, Pagnoux C, Mahr A, Ar\u00e8ne JP, Mouthon L, Le Guern V, et al. Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007;57(4):686\u201393.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2258_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ndt\/gfx378","volume":"34","author":"SP McAdoo","year":"2019","unstructured":"McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transpl. 2019;34(1):63\u201373.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"2258_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/BOR.0b013e32834d5730","volume":"24","author":"R Cartin-Ceba","year":"2012","unstructured":"Cartin-Ceba R, Fervenza FC, Specks U. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab. Curr Opin Rheumatol. 2012;24(1):15\u201323.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"2258_CR59","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/ar4313","volume":"15","author":"J Thiel","year":"2013","unstructured":"Thiel J, H\u00e4ssler F, Salzer U, Voll RE, Venhoff N. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Arthritis Res Ther. 2013;15(5):R133.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2258_CR60","doi-asserted-by":"publisher","first-page":"e000905","DOI":"10.1136\/rmdopen-2019-000905","volume":"5","author":"V Teixeira","year":"2019","unstructured":"Teixeira V, Mohammad AJ, Jones RB, Smith R, Jayne D. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis. RMD Open. 2019;5(1):e000905.","journal-title":"RMD Open"},{"issue":"2","key":"2258_CR61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","volume":"75","author":"AJ Mohammad","year":"2016","unstructured":"Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, et al. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. 2016;75(2):396\u2013401.","journal-title":"Ann Rheum Dis"},{"key":"2258_CR62","unstructured":"Terrier B, Pugnet G, de Moreuil C, Bonnotte B, Benhamou Y, Diot E, et al. Rituximab versus Conventional Therapeutic Strategy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: A Double-blind, Randomized, Controlled Trial [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9)."},{"issue":"6","key":"2258_CR63","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.kint.2021.08.025","volume":"100","author":"K Gulati","year":"2021","unstructured":"Gulati K, Edwards H, Prendecki M, Cairns TD, Condon M, Galliford J, et al. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2021;100(6):1316\u201324.","journal-title":"Kidney Int"},{"issue":"2","key":"2258_CR64","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ekir.2017.11.004","volume":"3","author":"FB Cortazar","year":"2018","unstructured":"Cortazar FB, Muhsin SA, Pendergraft WF, Wallace ZS, Dunbar C, Laliberte K, et al. Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep. 2018;3(2):394\u2013402.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2258_CR65","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):S1\u2013276.","journal-title":"Kidney Int"},{"issue":"3","key":"2258_CR66","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/BOR.0000000000000873","volume":"34","author":"JA Ford","year":"2022","unstructured":"Ford JA, Aleatany Y, Gewurz-Singer O. Therapeutic advances in eosinophilic granulomatosis with polyangiitis. Curr Opin Rheumatol. 2022;34(3):158\u201364.","journal-title":"Curr Opin Rheumatol"},{"key":"2258_CR67","doi-asserted-by":"crossref","unstructured":"Srikantharajah M, Ratnayake A, Ward K, Cairns T, Pusey C, Cole G et al. #1739 combination rituximab & low-dose IV cyclophosphamide induction therapy for severe multi-system eosinophilic granulomatosis with polyangiitis. Nephrol Dialysis Transplantation. 2024;39(Supplement_1).","DOI":"10.1093\/ndt\/gfae069.445"},{"issue":"7","key":"2258_CR68","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/acr2.11571","volume":"5","author":"B Terrier","year":"2023","unstructured":"Terrier B, Jayne DRW, Hellmich B, Bentley JH, Steinfeld J, Yancey SW, et al. Clinical benefit of mepolizumab in eosinophilic granulomatosis with polyangiitis for patients with and without a vasculitic phenotype. ACR Open Rheumatol. 2023;5(7):354\u201363.","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"2258_CR69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11886-024-02184-6","volume":"27","author":"AM Asada","year":"2025","unstructured":"Asada AM, Kahwash R, Trovato V. Eosinophilic myocarditis: A concise review. Curr Cardiol Rep. 2025;27(1):38.","journal-title":"Curr Cardiol Rep"},{"issue":"20","key":"2258_CR70","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","volume":"376","author":"ME Wechsler","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017;376(20):1921\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"2258_CR71","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.41943","volume":"74","author":"A Bettiol","year":"2022","unstructured":"Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, et al. Mepolizumab for eosinophilic granulomatosis with polyangiitis: A European multicenter observational study. Arthritis Rheumatol. 2022;74(2):295\u2013306.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"2258_CR72","first-page":"863","volume":"40","author":"F Bello","year":"2022","unstructured":"Bello F, Emmi G, Tamburini C, Maggi L, Annunziato F, Cosmi L, et al. Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1\/Th17-mediated vasculitic response. Clin Exp Rheumatol. 2022;40(4):863\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"2258_CR73","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","volume":"125","author":"R Kolbeck","year":"2010","unstructured":"Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, et al. MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol. 2010;125(6):1344\u2013e13532.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2258_CR74","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa2311155","volume":"390","author":"ME Wechsler","year":"2024","unstructured":"Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, et al. Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2024;390(10):911\u201321.","journal-title":"N Engl J Med"},{"key":"2258_CR75","doi-asserted-by":"publisher","first-page":"108574","DOI":"10.1016\/j.clim.2020.108574","volume":"222","author":"AGA Kolios","year":"2021","unstructured":"Kolios AGA, Lutterotti A, Kulcsar Z, Renner T, Rudiger A, Nilsson J. Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis. Clin Immunol. 2021;222:108574.","journal-title":"Clin Immunol"},{"issue":"9","key":"2258_CR76","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1016\/j.jaip.2021.04.067","volume":"9","author":"M Groh","year":"2021","unstructured":"Groh M, Pineton de Chambrun M, Georges JL, Panel K, Lef\u00e8vre G, Kahn JE, et al. Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab. J Allergy Clin Immunol Pract. 2021;9(9):3497\u2013e34991.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2258_CR77","first-page":"834","volume":"40","author":"N Belfeki","year":"2021","unstructured":"Belfeki N, Abroug S, Ghriss N, Chouchane I, Hamrouni S, Strazzulla A, et al. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis. Clin Exp Rheumatol. 2021;40(4):834\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"2258_CR78","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard-2023-224624","volume":"82","author":"A Cottu","year":"2023","unstructured":"Cottu A, Groh M, Desaintjean C, Marchand-Adam S, Guillevin L, Puechal X, et al. Benralizumab for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2023;82(12):1580\u20136.","journal-title":"Ann Rheum Dis"},{"key":"2258_CR79","doi-asserted-by":"publisher","first-page":"1204444","DOI":"10.3389\/fimmu.2023.1204444","volume":"14","author":"S Nolasco","year":"2023","unstructured":"Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, et al. Effectiveness and safety of anti-IL-5\/R\u03b1 biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study. Front Immunol. 2023;14:1204444.","journal-title":"Front Immunol"},{"issue":"1","key":"2258_CR80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.amjms.2022.07.007","volume":"365","author":"G Tsioulos","year":"2023","unstructured":"Tsioulos G, Kounatidis D, Vallianou NG, Koufopoulos N, Katsimbri P, Antoniadou A. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab. Am J Med Sci. 2023;365(1):93\u20138.","journal-title":"Am J Med Sci"},{"issue":"1","key":"2258_CR81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/mrcr\/rxab022","volume":"6","author":"K Higashitani","year":"2022","unstructured":"Higashitani K, Yoshimi R, Sato Y, Watanabe T, Ihata A. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis. Mod Rheumatol Case Rep. 2022;6(1):87\u201392.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"2258_CR82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1081-1206(10)61714-0","volume":"92","author":"N Tsurikisawa","year":"2004","unstructured":"Tsurikisawa N, Taniguchi M, Saito H, Himeno H, Ishibashi A, Suzuki S, et al. Treatment of Churg-Strauss syndrome with high-dose intravenous Immunoglobulin. Ann Allergy Asthma Immunol. 2004;92(1):80\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"2258_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/1346-8138.15709","volume":"48","author":"T Ikeda","year":"2021","unstructured":"Ikeda T, Komatsu T, Yokoyama K, Takahashi K, Kawakami T. Early add-on administration of mepolizumab and intravenous Immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis. J Dermatol. 2021;48(4):529\u201332.","journal-title":"J Dermatol"},{"issue":"2","key":"2258_CR84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2332\/allergolint.R-07-142","volume":"56","author":"M Taniguchi","year":"2007","unstructured":"Taniguchi M, Tsurikisawa N, Higashi N, Saito H, Mita H, Mori A, et al. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous Immunoglobulin therapy. Allergol Int. 2007;56(2):97\u2013103.","journal-title":"Allergol Int"},{"key":"2258_CR85","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","volume":"199","author":"MR Hazebroek","year":"2015","unstructured":"Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015;199:170\u20139.","journal-title":"Int J Cardiol"},{"issue":"17","key":"2258_CR86","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(17):1757\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2258_CR87","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1570161118666200130093432","volume":"18","author":"S Soulaidopoulos","year":"2020","unstructured":"Soulaidopoulos S, Madenidou AV, Daoussis D, Melissaropoulos K, Mavrogeni S, Kitas G, et al. Cardiovascular disease in the systemic vasculitides. Curr Vasc Pharmacol. 2020;18(5):463\u201372.","journal-title":"Curr Vasc Pharmacol"},{"issue":"33","key":"2258_CR88","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636\u201348.","journal-title":"Eur Heart J"},{"key":"2258_CR89","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","volume":"218","author":"A Iqubal","year":"2019","unstructured":"Iqubal A, Iqubal MK, Sharma S, Ansari MA, Najmi AK, Ali SM, et al. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci. 2019;218:112\u201331.","journal-title":"Life Sci"},{"issue":"1","key":"2258_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15171\/jrip.2017.04","volume":"6","author":"W Cheungpasitporn","year":"2017","unstructured":"Cheungpasitporn W, Kopecky SL, Specks U, Bharucha K, Fervenza FC. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Ren Inj Prev. 2017;6(1):18\u201325.","journal-title":"J Ren Inj Prev"},{"issue":"Suppl 2","key":"2258_CR91","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.1016\/j.ihj.2015.10.374","volume":"68","author":"SK Verma","year":"2016","unstructured":"Verma SK. Updated cardiac concerns with rituximab use: A growing challenge. Indian Heart J. 2016;68(Suppl 2):S246\u20138.","journal-title":"Indian Heart J"},{"issue":"12","key":"2258_CR92","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/eji.201646557","volume":"46","author":"NL Diny","year":"2016","unstructured":"Diny NL, Hou X, Barin JG, Chen G, Talor MV, Schaub J, et al. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur J Immunol. 2016;46(12):2749\u201360.","journal-title":"Eur J Immunol"},{"issue":"8","key":"2258_CR93","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.4049\/jimmunol.1301282","volume":"191","author":"JG Barin","year":"2013","unstructured":"Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Fairweather D, et al. Fatal eosinophilic myocarditis develops in the absence of IFN-\u03b3 and IL-17A. J Immunol. 2013;191(8):4038\u201347.","journal-title":"J Immunol"},{"issue":"1","key":"2258_CR94","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","volume":"10","author":"PA Lyons","year":"2019","unstructured":"Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun. 2019;10(1):5120.","journal-title":"Nat Commun"},{"key":"2258_CR95","doi-asserted-by":"crossref","unstructured":"Kotas ME, Dion J, Van Dyken S, Ricardo-Gonzalez RR, Danel CJ, Taill\u00e9 C et al. A role for IL-33-activated ILC2s in eosinophilic vasculitis. JCI Insight. 2021;6(12).","DOI":"10.1172\/jci.insight.143366"},{"issue":"7","key":"2258_CR96","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group. Avacopan for the treatment of ANCA-Associated vasculitis. N Engl J Med. 2021;384(7):599\u2013609.","journal-title":"N Engl J Med"},{"issue":"7","key":"2258_CR97","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/all.15670","volume":"78","author":"AV Wiese","year":"2023","unstructured":"Wiese AV, Duhn J, Korkmaz R\u00dc, Quell KM, Osman I, Ender F, et al. C5aR1 activation in mice controls inflammatory eosinophil recruitment and functions in allergic asthma. Allergy. 2023;78(7):1893\u2013908.","journal-title":"Allergy"},{"issue":"7","key":"2258_CR98","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/eji.1830260723","volume":"26","author":"J Elsner","year":"1996","unstructured":"Elsner J, Oppermann M, Kapp A. Detection of C5a receptors on human eosinophils and Inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies. Eur J Immunol. 1996;26(7):1560\u20134.","journal-title":"Eur J Immunol"},{"key":"2258_CR99","doi-asserted-by":"crossref","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin P, Le, et al. The Five-Factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort. Medicine. 2011;90(1):19\u201327.","DOI":"10.1097\/MD.0b013e318205a4c6"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-025-02258-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:02:31Z","timestamp":1772096551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-025-02258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1007\/s11886-025-02258-z","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"17 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update Fig. 2 and correct the section level heads.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"HWM has EGPA research funding from AstraZeneca via a grant award to SS.SS reports grant awards for EGPA from AstraZeneca, and Advisory services for EGPA for AstraZeneca and GSK; consulting fees from AstraZeneca, GSK, Chiesi, Sanofi, and Areteia; payments for educational events for EGPA from GSK and AstraZeneca; and the Steering Group for BSAR guidelines for ANCA associated vasculitis. SPM reports research funding from AstraZeneca, GSK, and Senya Therapeutics to his institution; consulting fees from Vifor, Alexion, and AstraZeneca; personal fees from Vifor; participation on a Data Safety Monitoring Board or Advisory Board for Obivas TSC (Roche sponsor); co-chair UKIVAS, and BSR Guidelines Group for ANCA vasculitis. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"109"}}